title: Progress in Cancer Treatment by Orthomolecular, Food, and Water Medicine
author:  Dr. Manal Mohamed Khowdiary 
description: Dr. Abdelfattah M. Badawi is presently professor of applied organic chemistry in the Egyptian Petroleum Research and General Secretary for the International Society of Therapeutic, Experimental and Clinical Research Bastia, France. He received his undergraduate training in chemistry at Cairo University and DSc degree in applied organic chemistry at Toronto University. He has been a visiting professor at Arkansas University for Medical Sciences in USA. His research interests are in the areas of both environmental chemistry and medicinal chemistry with special emphasis on antitumor agents. He recently got Science and Technology Development Fund (STDF) from the Egyptian Ministry of Scientific Research for two years as principal investigator for research project on ascorbate combined with surface-active germanium complexes and their nano-analogues for therapy of hepatitis C, cancers, and prevention of petroleum-induced carcinogenesis. Dr Manal M. Khowdiary is associate professor of applied physical chemistry in the Egyptian Petroleum Research Institute (Applied Surfactant Laboratory) and associate professor of physical chemistry in Umm El Qura University Chemistry Department. He received his undergraduate training in chemistry at Helwan University and PhD degree in physical chemistry from Ain Shams University. He participated in the research of applied surfactant, metallosurfactant chemistry and nanotechnology. His research interests are in the areas of both environmental chemistry and medicinal chemistry with special emphasis on antitumor agents. His current research involves investigations on metal-based drugs. Additional interests include the development of biocides and investigation of nanotechnology for destruction of tumors.
zlib_text: AMITROLE 
  CAS No. 61-82-5 
  First Listed in the Second Annual Report on Carcinogens 
  N
  NH2
  HN
  N
  CARCINOGENICITY
  Amitrole is reasonably anticipated to be a human carcinogen based on sufficient 
  evidence of carcinogenicity in experimental animals (IARC 1974, 1982, 1986, 1987, 2001).
  When administered in the diet, amitrole increased the incidence of hepatocellular carcinomas and
  adenomas in mice of both sexes. When administered to weanling mice of both sexes by gavage
  and followed by dietary administration, amitrole induced tumors of the thyroid and increased the
  incidence of tumors of the liver.
  When mice of both sexes were nursed by dams fed diets
  containing amitrole, the incidence of hepatocellular carcinomas and adenomas was increased in 
  males, but not females. When administered topically, amitrole did not induce skin tumors in 
  mice of both sexes.
  One study of transplacental exposure to amitrole by mice yielded
  inconclusive results. When administered in the diet, amitrole induced mal